BioCentury
ARTICLE | Company News

Oculus, More Pharma Corp. sales and marketing update

August 20, 2012 7:00 AM UTC

Oculus granted More Pharma an exclusive license to its Microcyn-based products in Mexico, South and Central America, and the Caribbean. Oculus will receive a $5.1 million upfront payment from More Pharma. The products covered under the deal are approved in Mexico. More Pharma will be responsible for seeking regulatory approval in other regions covered under the deal. Oculus will remain responsible for manufacturing the products. ...